Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, June, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: archive
2012
PHARMAC documents that matched your search:
Proposal to list propylthiouracil; Closing Date: Closed; Contact: Christine Chapman
(2 pages, 111 KB)
2012/03/28
28 March 2012 Proposal to list propylthiouracil AFT Pharmaceuticals Ltd’s brand of PHARMAC is seeking feedback on a proposal to fund propylthiouracil tablets from 1 May 2012 through a provisional agreement with AFT Pharmaceuticals Ltd (AFT). In summary, this proposal…
Proposal to amend the Special Authority criteria for sunitinib; Closing Date: Closed; Contact: Jackie Evans
(2 pages, 128 KB)
2012/03/01
01 March 2012 Proposal to Amend the Special Authority Criteria for Sunitinib PHARMAC is seeking feedback on a proposal to amend the Special Authority criteria applying to sunitinib cap 12.5 mg, 25 mg and 50 mg (Sutent) for the treatment…
Proposal to amend access criteria for dornase alfa; Closing Date: Closed; Contact: Christine Chapman
(4 pages, 131 KB)
2012/02/29
29 February 2012 Proposal to amend the funding criteria for dornase alfa PHARMAC has signed a provisional agreement with Roche Products (New Zealand) Ltd for the supply of dornase alfa for the treatment of cystic fibrosis patients. In summary, it…
Proposal to fund prasugrel; Closing Date: Closed; Contact: Sue Anne Yee
(2 pages, 114 KB)
2012/02/20
20 February 2012 Proposal to fund prasugrel PHARMAC is seeking feedback on a proposal to fund prasugrel hydrochloride (Effient) through a provisional agreement with Eli Lilly. In summary, this proposal would result in prasugrel hydrochloride (Effient) being fully funded from…
Amend restrictions relating to various ophthalmology products; Closing Date: Closed; Contact: Greg Williams
(3 pages, 158 KB)
2012/02/03
3 February 2012 Proposal to amend restrictions relating to various ophthalmology products. PHARMAC is seeking feedback on proposals to remove the prescribing guidelines currently in Part B of the Pharmaceutical Schedule for glaucoma preparations and to include several ophthalmology products…
Proposal to fund lapatinib and pazopanib and amend funding criteria for trastuzumab; Closing Date: Closed; Contact: Jackie Evans
(7 pages, 154 KB)
2012/01/26
26 January 2012 Proposal to fund lapatinib and pazopanib and amend funding criteria for trastuzumab PHARMAC is seeking feedback on a proposal to: Fund lapatinib (Tykerb) as an alternative to trastuzumab (Herceptin) for the first line treatment of patients…
Widen access to ursodeoxycholic acid; Closing Date: Closed; Contact: Natalie Davis
(2 pages, 126 KB)
2012/01/20
20 January 2012 Proposal to widen access to ursodeoxycholic acid PHARMAC is seeking feedback on a proposal to widen funded access to ursodeoxycholic acid for prevention of veno-occlusive disease in patients receiving high dose conditioning therapy prior to bone marrow…
Proposal to fully fund Symbicort Turbuhaler and Vannair; Closing Date: Closed; Contact: Christine Chapman
(3 pages, 127 KB)
2012/01/17
17 January 2012 Proposal to fully fund Symbicort Turbuhaler and Vannair PHARMAC is seeking feedback on a proposal to fully subsidise budesonide with eformoterol (Symbicort Turbuhaler and Vannair) from 1 March 2012 through a provisional agreement with AstraZeneca. In summary,…
